Fran Martin

Fran Martin is an accomplished pharmaceutical executive with end-to-end commercialization expertise encompassing discovery, development, launch and lifecycle management . While at GlaxoSmithKline, Fran played significant roles in successfully launching four products across the HIV, neurosciences, respiratory, and overactive bladder therapeutic areas. She built market presence and established unique and differentiated product platforms through her ability to marry exquisite customer insight with extensive knowledge of the scientific data and regulatory environment. From 2005-2010, Fran held the position of Vice President of Global Product Strategy, Infectious Diseases, where she re-invented the product strategy and re-established the corporate ID pipeline, through a range of in-licensing, partnering, risk sharing, and investment deals. This diverse approach resulted in 5 early discovery antibiotic collaborations yielding PoC in 18 months and established ViiV Healthcare, an independent HIV company, through an 85/15 (GSK/Pfizer) business collaboration. Other leadership roles included such diverse areas as Marketing and Sales, R&D, Business Development, Managed Markets, Patient Advocacy and New Product Planning. Fran holds a Bachelor’s degree in Pharmacy from the University of Pittsburgh, where she graduated Magna Cum Laude. She continues to practice pharmacy at the Open Door Clinic providing outreach to underserved communities and serves on the board of the Cystic Fibrosis Foundation of the Carolinas.